Cimetidin og ranitidin øger biotilgængeligheden af risperidon, men den aktive antipsykotiske fraktions biotilgængelighed påvirkes kun marginalt.
In addition, long-acting risperidone offers an advantage in increased compliance to the treatment, which could result in more stable plasma levels of risperidone.